XTL Biopharmaceuticals (NASDAQ: XTLB) Announces Change to ADS Ratio
Expert Analysis The decision by XTL Biopharmaceuticals (NASDAQ: XTLB) to adjust the ratio of its American Depositary Shares (ADSs) relative to its ordinary shares signals a strategic move to recalibrate its share structure. Such an adjustment can impact trading dynamics and investor perceptions, potentially enhancing liquidity and aligning the ADS structure more closely with market norms. The move from one ADS representing one hundred shares to one ADS representing four…
